Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Egypt reforms obsolete pharmaceutical pricing framework
In late September 2026, the Egyptian Drug Authority (EDA) published Decree No.480 of 2026 in the Official Gazette.
Read Full Article
Pharma Tech
Gilead spends $1.28bn on PepStar’s potential Icotyde rivalÂ
Gilead plans to develop HCXT-2001 both as a monotherapy and in combination with its own IBD hopeful, emvistegrast.
Read Full Article
Express Pharma
Amneal Pharmaceuticals inaugurates Rs 135 crore office in Ahmedabad
The 3.35 lakh sq ft facility will accommodate around 1,200 employees and support the company’s operations in India The post Amneal Pharmaceuticals inaugurates Rs 135 crore office in Ahmedabad appeared first on Express Pharma.
Read Full Article
Pharma Tech
Boehringer and Microsoft collaborate to explore AI in clinical research
Boehringer Ingelheim and Microsoft have entered into a strategic collaboration to examine the use of AI in clinical research, beginning with studies in lung health.
Read Full Article
Pharma Tech
Celltrion and Kaigene sign $580m licence deal for KG013
Celltrion has acquired exclusive global development and commercialisation rights to Kaigene's investigational monoclonal antibody, KG013, in a deal worth up to $580m.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 23, 2026, 11:18 PM
Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Obeda Pro and Obeda Plus are manufactured by a different firm than the Obeda injectable, supplies of which were halted after Dr Reddy's found an impurity in the active ingredient.
Pharma Tech
Oct 23, 2026, 1:33 PM
Egypt reforms obsolete pharmaceutical pricing framework
In late September 2026, the Egyptian Drug Authority (EDA) published Decree No.480 of 2026 in the Official Gazette.
PharmaShots
Oct 23, 2026, 12:19 PM
Zymeworks Inks ~$813M Deal with Roche to Advance ZW209
Shots: Ref: Zymeworks |  Image: Zymeworks & Roche  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Zymeworks Inks ~$813M Deal with Roche to Advance ZW209 appeared first on PharmaShots.
PharmaShots
Oct 23, 2026, 12:16 PM
IDEAYA Reports Updated P-I Data of IDE849 (SHR-4849) for Relapsed SCLC and Neuroendocrine Carcinomas at ESMO 2026
Shots: IDEAYA’s partner Hengrui has presented updated P-I study data of IDE849 (SHR-4849; DLL3 TOP1 ADC) in 122 pts with relapsed SCLC & other NECs in China at ESMO 2026 In 2L SCLC, the therapy showed 72.5% ORR, mOS of 17.4mos & mPFS of 6.9mos, with 65.4% cORR in pts with brain metastases & 52.6%… The post IDEAYA Reports Updated P-I Data of IDE849 (SHR-4849) for Relapsed SCLC and Neuroendocrine Carcinomas at ESMO 2026 appeared first on PharmaShots.
PharmaShots
Oct 23, 2026, 12:15 PM
Alnylam Reports Initial P-Ib Trial Data of Brezosiran (ALN-HTT02) for Huntington’s Disease
Shots: Alnylam has reported initial P-Ib trial data of brezosiran (ALN-HTT02; intrathecal RNAi therapeutic) in 48 adults with HD-ISS Stage 2 or early Stage 3 Huntington’s disease across 5 single-dose cohorts, presented at EHDN 2026 The highest dose showed a mean CSF mHTT reduction of 60-64% at M3 (maximum individual reduction: 83%), with durability supporting… The post Alnylam Reports Initial P-Ib Trial Data of Brezosiran (ALN-HTT02) for Huntington’s Disease appeared first on PharmaShots.
Pharma Tech
Oct 23, 2026, 11:07 AM
Gilead spends $1.28bn on PepStar’s potential Icotyde rivalÂ
Gilead plans to develop HCXT-2001 both as a monotherapy and in combination with its own IBD hopeful, emvistegrast.
News
Latest industry coverage
Google News
Oct 24, 2026, 7:00 AM
How contest between Chinese and Indian firms could reshape African drug markets - South China Morning Post
How contest between Chinese and Indian firms could reshape African drug markets  South China Morning Post
Google News
Oct 24, 2026, 5:45 AM
Lupin appoints Brian Savage as president, chief legal officer - Pharmabiz.com
Lupin appoints Brian Savage as president, chief legal officer  Pharmabiz.com
Google News
Oct 24, 2026, 5:41 AM
ADAPTIVE INDOMITABLE UKRAINE: Despite Putin’s Bombs, UKR Critical Drug & Medical Supplies Stand - Daily Kos
ADAPTIVE INDOMITABLE UKRAINE: Despite Putin’s Bombs, UKR Critical Drug & Medical Supplies Stand  Daily Kos
Google News
Oct 24, 2026, 5:39 AM
Keralam Health Minister Defends Switch To Indian-Made SMA Drug, Says Supply Will Continue - News18
Keralam Health Minister Defends Switch To Indian-Made SMA Drug, Says Supply Will Continue  News18
Google News
Oct 24, 2026, 5:24 AM
Kilitch Drugs to divest Ethiopian arm for $14 million - The Hindu
Kilitch Drugs to divest Ethiopian arm for $14 million  The Hindu
Google News
Oct 24, 2026, 5:06 AM
Health Brief: Making sense of Treasury’s biotech deal proposal - The Washington Post
Health Brief: Making sense of Treasury’s biotech deal proposal  The Washington Post
Google News
Oct 24, 2026, 3:44 AM
Korea pharma and biotech pivot to AI to power senior health care boom - CHOSUNBIZ - Chosunbiz
Korea pharma and biotech pivot to AI to power senior health care boom - CHOSUNBIZÂ Â Chosunbiz
Google News
Oct 24, 2026, 3:37 AM
330 Drug Samples Fail Quality Tests Across India, 93 From Himachal - The News Himachal
330 Drug Samples Fail Quality Tests Across India, 93 From Himachal  The News Himachal
Google News
Oct 24, 2026, 1:20 AM
Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks - Yahoo Finance
Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks  Yahoo Finance
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer